(Q40497868)
Statements
Phase I to II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in patients with advanced chronic lymphocytic leukemia (English)
Susan M O'Brien
Charles C Cunningham
Anatoliy K Golenkov
Steven C Novick
26 September 2005